港股异动|PLATTNERA大幅飙升20%续创新高7日累升近100%
格隆汇8月16日丨次新股PLATT NERA(1949.HK)大幅飙升20.1%,报2.45港元,盘中再创新高。暂成交2110万港元,最新总市值9.8亿港元。公司股价上市初期持续下跌,近7个交易日持续大幅飙升,累计涨幅近100%。Platt Nera是泰国成熟的IT解决方案供应商。该集团截至2018年9月30日止九个月,收益约3.65亿泰铢(约9126万港元),同比增长约54.48%;净溢利约7513.4万泰铢(约1878.4万港元),同比上升16.46%。值得注意的是,该股将于8月22日(周四)公布中期业绩报告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.